# A Study of LY3200327 in Healthy Participants

> **NCT02595736** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo (SC)
- **DRUG:** LY3200327 (SC)
- **DRUG:** LY3200327 (IV)
- **DRUG:** Placebo (IV)

## Key facts

- **NCT ID:** NCT02595736
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595736, "A Study of LY3200327 in Healthy Participants". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02595736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*